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Abstract 20 
Hepatitis C virus (HCV) requires proteins from the NS3-NS5B polyprotein to create a replicase 21 
unit for replication of its genome. The replicase proteins form membranous compartments in 22 
cells to facilitate replication, but little is known about their functional organization within these 23 
structures. We recently reported on intragenomic replicons, bicistronic viral transcripts 24 
expressing an authentic replicase from ORF2 and a second duplicate NS polyprotein from ORF1. 25 
Using these constructs and other methods, we have assessed polyprotein requirements needed for 26 
rescue of different lethal point mutations across NS3-5B. Mutations readily tractable to rescue 27 
broadly fell into two groupings; those requiring expression of a minimum NS3-5A and those 28 
requiring expression of a minimum NS3-5B polyprotein. A cis-acting mutation that blocked NS3 29 
helicase activity, T1299A, was tolerated when introduced into either ORF within the 30 
intragenomic replicon, but unlike many other mutations required the other ORF to express a 31 
functional NS3-5B. Three mutations were identified as more refractile to rescue; one that 32 
blocked cleavage of the NS4B5A boundary (S1977P), another in the NS3 helicase (K1240N) and 33 
a third in NS4A (V1665G). Introduced into ORF1, these exhibited a dominant negative 34 
phenotype, but with K1240N inhibiting replication as a minimum NS3-5A polyprotein whereas 35 
V1665G and S1977P only impaired replication as a NS3-5B polyprotein. Furthermore, a S1977P 36 
mutated NS3-5A polyprotein complemented other defects shown to be dependent on NS3-5A for 37 
rescue.  Overall, our findings suggest the existence of two inter-dependent sets of protein 38 
complexes supporting RNA replication, distinguishable by the minimum polyprotein 39 
requirement needed for their formation.  40 
 41 
  42 
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Importance 43 
Positive strand RNA viruses reshape the intracellular membranes of cells to form a compartment 44 
within which to replicate their genome, but little is known about functional organization of viral 45 
proteins within this structure. We have complemented protein-encoded defects in HCV by 46 
constructing sub-genomic HCV transcripts capable of simultaneously expressing both a mutated 47 
and functional polyprotein precursor needed for RNA genome replication (intragenomic 48 
replicons). Our results reveal that HCV relies on two interdependent sets of protein complexes to 49 
support viral replication. They also show that the intragenomic replicon offers a unique way to 50 
study replication complex assembly as it enables improved composite polyprotein complex 51 
formation compared to traditional trans-complementation systems. Finally, the differential 52 
behaviour of distinct NS3 helicase knock-out mutations hints that certain conformations of this 53 
enzyme might be particularly deleterious for replication. 54 
  55 
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Introduction 56 
Exposure to hepatitis C virus (HCV) often results in chronic infection and can lead to 57 
liver-related mortality and morbidity. Intensive research efforts since discovery of the virus have 58 
translated into improved patient care, with the recent advent of direct acting antiviral (DAA) 59 
therapy now providing high cure rates, particularly in genotype (gt)1-infected patients (1). 60 
However, certain aspects of viral replication remain poorly understood, including how viral 61 
proteins associate with each other and host proteins to form the platforms that support replication 62 
of the viral genome. 63 
 HCV has a single-stranded, positive-sense RNA genome of 9.6kb in length that contains 64 
a single open reading frame (ORF) flanked by 5’ and 3’ untranslated regions (UTRs) (2). 65 
Translation of the ORF is driven by an internal ribosome entry site (IRES) within the 5’UTR (3), 66 
resulting in the production of a polyprotein, which is cleaved co- and post-translationally by 67 
host- and virus-encoded proteases to give rise to the mature viral proteins. The latter two thirds 68 
of the polyprotein encompass the NS3-5B replicase unit (NS3, NS4A, NS4B, NS5A and NS5B), 69 
which provides the viral proteins that are sufficient for genome replication (4). NS3 is the 70 
protease responsible for NS3-5B processing and also provides essential helicase activity, 71 
encoded within its C-terminal domain (5). It is anchored to the ER membrane by both an 72 
amphipathic helix and by its protease co-factor NS4A (5). RNA polymerase activity is provided 73 
by NS5B (6). The functions of NS4B and NS5A are less well understood, although both proteins 74 
bind RNA (7, 8).  75 
 In infected cells, viral RNA synthesis occurs in virus-induced cytoplasmic compartments 76 
referred to as membranous webs or membrane-associated foci (MAF) (9). Morphologically, 77 
these compartments appear as a collection of ER-derived single- and double-membrane vesicles 78 
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(10). Current evidence points to the double-membrane vesicles as the site for polymerase activity 79 
and hence RNA replication (11). Expression of polyproteins encoding NS3-5A or NS3-5B, leads 80 
to the formation of MAF-like structures in the absence of replication (10). Double-membrane 81 
vesicles are also present in cells expressing NS5A alone (10), and both drugs and mutations that 82 
target NS4B and NS5A disrupt MAF architecture (12-15); this suggests that NS4B and NS5A 83 
are key structural components of these assemblies.  84 
 Genetic complementation of mutations that block replication offers a way to gain insight 85 
into functions of viral NS proteins in RNA replication. From early studies with gt1b replicons, 86 
most mutations in the HCV replicase were refractile to rescue, except for a few mutations in the 87 
low complexity sequence 1 (LCS1) region between domains 1 and 2 in NS5A (16). Subsequent 88 
analysis using replicons encoding strain JFH-1 (gt2a) sequences, which give higher levels of 89 
replication, revealed mutations in other NS5A regions as well as NS4B mutations could be 90 
rescued, albeit less efficiently than LCS1 mutations (14, 17). The range of mutations that can be 91 
rescued has recently been extended to include NS3, NS4A and NS5B by using Venezuelan 92 
Equine Encephalitis Virus (VEEV) replicons to express high levels of NS3-5B (18).  93 
All of the above approaches have relied on supplying functional counterparts of proteins 94 
in trans that are expressed from separate transcripts to rescue defective NS3-5B replicase units. 95 
Recently, we reported an alternative system to complement deleterious mutations using 96 
intragenomic HCV replicons that carry two ORFs (ORF1 and ORF2), each driven by separate 97 
IRES elements. Thus the complementing viral proteins are provided in trans from distinct 98 
translation units but encoded in cis from the same RNA molecule. Two advantages of our system 99 
were that a) complementing proteins were translated to a similar level compared to their non-100 
functional counterpart and b) functional and non-functional polyproteins could be translated in 101 
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close apposition. Using this approach, enhanced rescue of defective NS5A containing a S2208I 102 
mutation could be achieved by expressing a NS3-5A cassette in ORF1 compared to expressing 103 
NS5A alone (19). Enhanced rescue of this defective NS5A also correlated with the ability of 104 
NS3-5A to target the protein to MAF. However, despite the efficiency with which NS3-5A 105 
targeted NS proteins to the MAF, both its ability and the capacity of helper viruses expressing 106 
NS3-5B to complement NS4B defects remained limited. 107 
In this study, we set out to understand why rescue of certain mutations remained limited, 108 
despite efficient targeting of NS proteins to the MAF by NS3-5A using the intragenomic replicon 109 
system (19). By extending the capacity of ORF1 to express NS3-5B, our data reveal the 110 
existence of genetically distinguishable complexes that support HCV RNA replication.  111 
  112 
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Methods and Materials 113 
Cell lines. Generation of the SGR-JFH1neo replicon cell line has been described, as has 114 
propagation of this cell line and naive Huh7.5 cells (19, 20). 115 
Plasmid vectors - The production of pFBM-based baculovirus constructs for expression of JFH1 116 
NS34A, GFP-tagged versions of JFH1 NS5A expressed either alone or in the context of NS3-5A 117 
and NS3-5B, pSGR-FLAG constructs containing G1911A and S2208I mutations, and 118 
intragenomic replicon containing plasmids pRep_R2NS5AV5/NS3-5BFLAG and pRep_R2NS3-119 
5AV5/NS3-5BFLAG with either a functional ORF2, or an ORF2 containing S2208I and G1911A 120 
have been described (19).  121 
To extend intragenomic replicon ORF1 to express a Renilla-Foot and Mouth Disease Virus 2A 122 
(FMDV2A)-NS3-NS5B polyprotein containing a V5 epitope tag at the COOH-terminus of 123 
NS5A, two 1000 bp DNA Strings (Invitrogen) representing an entire synonymous codon altered 124 
NS5B sequence + NS5A5B boundary and flanked at the 3’ end by a stop codon,  Pme I site and 125 
M13(-20) primer site were synthesized. These DNA Strings along with LIT_Ren-2A-based 126 
vector containing the codon altered NS3-5AV5 sequence (LIT_Ren-2A-NS3-5AV5) (19) were 127 
used as templates in 3 separate PCR reactions involving primer pairs 1 + 2, 3 + 4 and 5 + 6 128 
(Table S1). All three products were combined in a second PCR reaction with primers 1 and 6, 129 
and the resulting DNA cloned back into LIT_Ren-2A-NS3-5AV5 via Sal I and Pme I restriction 130 
sites forming LIT_Ren-2A-NS3-5BV5 (for the codon altered NS3-5B(5AV5) sequence see 131 
Genbank, accession number KR140016). The Ren-2A-NS3-5BV5 expression cassette from this 132 
vector was cloned into existing pRep_R2NS3-5AV5/NS3-5BFLAG based vectors via Bgl II and 133 
Pme I restriction sites to generate pRep_R2NS3-5BV5/NS3-5BFLAG constructs where ORF2 was 134 
either functional or contained the ∆GDD, G1911A or S2208I mutations. The terminology in the 135 
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main body of text used to describe the transcripts generated from these constructs is wtNS3-136 
5B/wtNS3-5B, wtNS3-5B/∆GDDNS3-5B, etc. 137 
To produce intragenomic replicons expressing Ren-2A-NS34A, Ren-2A-NS5A5B and 138 
Ren-2A-NS5B cassettes, LIT_Ren-2A-NS3-5BV5 was used as a template in a PCR reaction with 139 
primers 7 + 8, 9 + 6 and 10 + 6 respectively. The resulting NS coding regions were transferred to 140 
a LIT_Ren-2A-based vector using Rsr II and Pme I restriction sites to produce LIT_Ren-2A-141 
NS34A, LIT_Ren-2A_NS5A5B and LIT_Ren-2A-NS5B. The expression cassettes from these 142 
vectors were cloned into existing intragenomic replicon containing plasmids via Bgl II and Pme I 143 
restriction sites.  144 
Introduction of the L1157A mutation into pSGR-FLAG (19) was through exchange of an 145 
Acc65 I - Spe I restriction fragment with that contained within the pCITE-NS3-3’/JFH1 vector 146 
containing this same mutation (2). Introduction of the S1977P mutation into pSGR-FLAG was 147 
through exchange of an Nsi I – Rsr II restriction fragment with that present in pFBM(NS3-148 
5AGFP)S1977P. Introduction of the other lethal mutations into pSGR-FLAG relied on a two-step 149 
PCR reaction using either JFH1 cDNA or pSGR-FLAG as template. Appropriate flanking 150 
primers were used in combination with internal mutagenic primers 11 + 12 (for PP1220-1GG), 151 
13 + 14 (for K1240N), 15 + 16 (for V1665G), 17 + 18 (for Y1706A), 19 + 20 (for S1977P), 21 + 152 
22 (for P2008A), 23 + 24 (for GDD>GAA), 25 + 26 (T1299A) and 27 + 28 (G2323A). (Note: 153 
for the G2323A mutation, a JFH1 template with a small number of silent substitutions including 154 
a 10 nucleotide poly C tract adjacent to the mutagenized codon was used to allow effective 155 
overlapping primer design. The modified sequence also lacked the BamH I site in NS5A but not 156 
in NS4B - sequence is available on request). Fragments generated were cloned into pSGR-FLAG 157 
via Cla I and Spe I (K1240N), Cla I and Nsi I (PP1220-1GG + T1299A), Nsi I and Rsr II 158 
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(V1665G + Y1706A + P2008A + S1977P), Sfi I and SnaB I (GDD>GAA) or BamH I and Rsr II 159 
(G2323A). Transfer of mutations from pSGR-FLAG into ORF2 of intragenomic replicon 160 
containing plasmids, took advantage of a set of unique restriction sites in a region of sequence 161 
identity shared by the two constructs, between the start of the EMCV IRES through to the end of 162 
the 3’UTR. 163 
Mutations in ORF1 of plasmids containing the intragenomic replicons were introduced 164 
by a two-step PCR approach using LIT_Ren-2A-NS3-5AV5 and/or LIT_Ren-2A-NS3-5BV5 as 165 
templates. Appropriate flanking primers were used in combination with internal mutagenic 166 
primers 29 + 30 (for K1240N), 31 + 32 (for S1977P), 33 + 34 (for GDD>GAA), 35 + 36 (for 167 
T1299A), 37 + 38 (for G1911A) and 39 + 40 (for V1665G). The resultant DNA was cloned back 168 
into LIT_Ren-2A-NS3-5AV5 and/or LIT_Ren-2A-NS3-5BV5 via either Rsr II and Mlu I 169 
(K1240N), Nde I and Sal I (G1911A + S1977P), Sal I and Pme I (GDD>GAA) or Not I + Mlu I 170 
(T1299A) restriction sites. The same approach was used to introduce the K1240N mutation into 171 
LIT_Ren-2A-NS34A, but with the PCR product being cloned back into this plasmid via Rsr II 172 
and Pme I sites. The expression cassettes from these vectors were cloned into existing 173 
intragenomic replicon containing plasmids via Bgl II and Pme I restriction sites. In the case of 174 
the V1665G mutation, cloning was directly into the intragenomic vector via Not I + Mlu I. 175 
To generate monocistronic replicons, pSGR-FLAG was used as a template in a PCR 176 
reaction with primers 41 and 42, and the resulting product cloned into pRep_R2NS3-5AV5/NS3-177 
5BFLAG via the two Rsr II sites present within the vector to generate pJFH1-mono (the DNA 178 
template for transcription of JFH1-mono). Both pRep_R2NS3-5BV5/NS3-5BFLAG and pJFH1-179 
mono were used as templates in a two-step PCR reaction with primer pairs 43 +44 and 45 + 46.  180 
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The resultant DNA, produced in the second round reaction with primers 43 and 46, was cloned 181 
into pJFH1-mono via Asc I and Sal I sites to generate the pDVR/JFH1@7667-mono.  182 
Sequence analysis. Analysis of the synonymous codon-altered sequence to establish the CpG and 183 
UpA motif frequencies was performed using Simple Sequence Editor software (21). 184 
Transient replication assays – Generation of T7 RNA transcripts and their electroporation into 185 
Huh7.5 cells or Huh7.5 cells previously transduced with baculovirus has been described (19). 186 
For all assays except those looking at the trans-dominant impact of K1240N on replication, cells 187 
were electroporated with 2 µg of RNA transcript. In the case of these latter assays, 1 µg of 188 
replication-competent JFH1-mono was transfected with 4 µg of either yeast tRNA or the 189 
replication-defective bicistronic SGR replicon. Cell lysates were harvested in 1 x passive lysis 190 
buffer (Promega) up to 96 hours post-transfection and luciferase activity measured. Firefly and 191 
Renilla luciferase activities were measured using the Bright-Glo Luciferase Assay system 192 
(Promega) and Renilla Luciferase Assay Kit (Biotium) according to manufacturer’s 193 
recommendations. For graphical representation, the background signal from mixing Passive 194 
Lysis Buffer only with luciferase reagent was subtracted from the raw data values. On some 195 
occasions where different experiments containing multiple experimental groups were performed 196 
in parallel, control experimental groups were shared between experiments (indicated in figure 197 
legends). 198 
Western blot analysis – Transfer of proteins to membranes and subsequent detection has been 199 
described (19). Antibodies used were anti-NS3 (BioFront), anti-GAPDH (Chemicon), anti-V5 200 
(gift from Prof. R. Randall, University of St Andrews), anti-FLAG (Biolegend) and anti-GFP 201 
(Biolegend). 202 
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Indirect immunofluorescence – 72 hours post-transfection cells were fixed with methanol at -203 
20ºC for 30 minutes, rehydrated with PBS, and blocked with PBS containing 2% FCS (PBS/FCS) 204 
for 10 minutes. Cells were then probed with anti-V5 and anti-FLAG antibodies for 1.5 hours at 205 
room temperature, washed extensively with PBS/FCS and finally incubated with anti-mouse-206 
Alexa594 and anti-rat-Alexa488 for 1 hour at room temperature. All antibody incubations were 207 
carried out in PBS/FCS. Cells were washed with PBS/FCS followed by PBS, rinsed with H2O 208 
and then mounted with Vectashield (Vector Laboratories) that contained DAPI to stain nuclei. 209 
Images were captured with a Zeiss LSM 710 confocal microscope.   210 
Northern blot analysis – Cellular RNA, extracted using TriFAST reagent (Peqlabs), was run on a 211 
formaldehyde-agarose gel and transferred by capillary action to positively charged Nylon 212 
membrane using standard procedures. DNA probes were biotinylated using the PlatinumBright 213 
labelling kit (Kreatech). Hybridization was performed using Ultrahyb (Ambion) according to 214 
manufacturer’s instructions and bound probe detected using the Bright Star detection kit 215 
(Ambion) and film-based exposure.  216 
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Results 217 
Replication of HCV RNA from two copies of the NS3-5B replicase unit in a single RNA molecule 218 
We recently described use of intragenomic replicons as a novel system to perform HCV 219 
complementation assays (Fig 1) (19). Using these constructs, we showed that the intracellular 220 
distribution of a V5-tagged NS5A, expressed from ORF1 as an NS3-5A polyprotein, extensively 221 
overlapped with a second copy of a FLAG-tagged NS5A produced from an ORF2-encoded 222 
replicase. Along with additional experimental data, the results were consistent with NS3-5A 223 
directing mature protein products from the polyprotein to MAF, but did not account for why 224 
expression of NS3-5A from ORF1 only allowed rescue of constructs carrying the NS5A S2208I 225 
mutation in ORF2, not a NS4B G1911A mutation (numbers refer to position of the residue in the 226 
JFH1 polyprotein). One possible explanation was the existence of more than one type of NS 227 
protein complex within MAF such that NS3-5A, being an incomplete component of the full 228 
NS3-5B replicase, only contributed to the formation of some of these complexes. Two 229 
alternative explanations were that linking the ORF1 polyprotein to a Renilla luciferase – Foot 230 
and Mouth Disease Virus (FMDV) 2A fusion protein, or use of a recoded NS sequence in ORF1, 231 
impacted on polyprotein function. To examine these last two possibilities, monocistronic 232 
replicons were generated in which the NS3-5B replicase was expressed as a Renilla-FMDV2A 233 
fusion protein (Fig 2a). For one replicon the NS protein coding region was derived from JFH1 234 
(JFH1-mono) but for the other it was chimeric, consisting of the NS3-5A recoded region fused to 235 
JFH1 NS5B (JFH1DVR-mono). Expressed polyproteins also encoded the same FLAG-tagged 236 
(JFH1-mono) and V5-tagged (JFH1DVR-mono) versions of NS5A present in ORF2 and ORF1 of 237 
the intragenomic replicon construct, the former already having been shown not to affect 238 
replicative function (19). Both replicons showed equally robust replication when transfected into 239 
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cells whereas a polymerase defective control monocistronic construct containing a GDD>GAA 240 
mutation (JFH1-mono(GDD>GAA)) did not replicate (Fig 2a). These data verify that neither 241 
linking a luciferase reporter to NS3-5B using FMDV 2A, nor use of recoded NS3-5A sequence, 242 
interfere with RNA replication. They also demonstrate that the presence of the V5 tag in recoded 243 
NS5A does not impair replicase function. 244 
To determine whether intragenomic replicons could be adapted for identifying distinct 245 
replication complexes (RCs), we then extended NS3-5A in ORF1 to encode NS3-5B such that 246 
the synthetic NS5B sequence, similar to the upstream NS3-5A segment, also contained 247 
synonymous changes across its coding region. The strategy to introduce synonymous changes 248 
was aimed at limiting the possibility of recombination with NS3-5B in ORF2, and had the added 249 
advantage of preventing duplication of cis-acting RNA elements (CREs) present in ORF2 (22, 250 
23). Transfection of the resultant wtNS3-5B/wtNS3-5B RNA into Huh7.5 cells gave robust replication 251 
(Fig 2b). To test whether the codon-modified NS3-5B sequences in ORF1 could direct 252 
replication, the GDD motif in the NS5B RNA polymerase in ORF2 was deleted (ΔGDD). This 253 
resultant intragenomic construct (wtNS3-5B/ΔGDDNS3-5B) gave luciferase activity at 72 hours, 254 
which was only about 3-fold lower than the replicon with wt sequences in ORFs1 and 2. 255 
Combining another polymerase knock-out mutation (GDD>GAA) in ORF1 with the ∆GDD 256 
mutation in ORF2 (giving GDD>GAANS3-5B/ΔGDDNS3-5B) blocked replication (Fig 2b). These 257 
data demonstrate that it is possible to express two functional copies of the HCV NS3-5B 258 
replicase unit from a single RNA molecule.  259 
Mutations in NS3, NS4B and NS5A that are refractile to rescue with NS3-5A. 260 
 To examine the effect of introducing other lethal mutations into ORF2 of the 261 
intragenomic replicon, constructs were made expressing either wt NS3-5A or NS3-5B from 262 
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ORF1 and a series of NS3-5B replicases carrying single lethal mutations from ORF2  (Fig 3). 263 
The first two of these mutations were the S2208I NS5A and G1911A NS4B mutations from our 264 
previous study (19), in which only S2208I could be complemented by NS3-5A expressed from 265 
ORF1. The third was another mutation in NS5A (P2008A), previously reported to be rescued by 266 
trans-complementation and chosen because it belonged to a different complementation group 267 
from the S2208I mutation (17). The final mutation was K1240N, located in the Walker A motif 268 
of the NS3 helicase and which blocks helicase activity by preventing NTP binding. 269 
  This series of replicons, and relevant polymerase-defective control constructs (wtNS3-270 
5A/GDD>GAANS3-5B), were transfected into Huh7.5 cells and luciferase activity was monitored 271 
over a 96 hour period (Fig 3). Replication was slightly lower for wtNS3-5B/wtNS3-5B compared to 272 
wtNS3-5A/wtNS3-5B, which may arise because of the increased length of the RNA from 273 
incorporating NS5B sequences into ORF1 of wtNS3-5A/wtNS3-5B. As predicted, wtNS3-274 
5A/GDD>GAANS3-5B did not replicate as the RNA only expresses a non-functional virus-encoded 275 
RNA polymerase. Similar to the results from wtNS3-5B/ΔGDDNS3-5B in Fig. 2, wtNS3-276 
5B/GDD>GAANS3-5B also showed robust replication. Results with the constructs containing other 277 
mutations in ORF2 revealed differences in replication between the experimental groups (Fig 3a). 278 
For the series of constructs expressing NS3-5A from ORF1, only the one carrying S2208I 279 
showed robust replication, whereas replication of constructs carrying all other mutations 280 
(G1911A, P2008A and K1240N) was absent. When ORF1 instead expressed NS3-5B, the 281 
relative replication of the construct with S2208I in ORF2 was enhanced compared to its wt 282 
counterpart, but more noticeable was the differences in replication for those constructs carrying 283 
the other mutations in ORF2. Constructs with P2008A and G1911A mutations replicated as well 284 
as had been observed for wtNS3-5B/GDD>GAANS3-5B. In theory, this was consistent with the 285 
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ability of ORF1 NS3-5B simply substituting for the functional replicase produced from ORF2 286 
NS3-5B. However, the same phenomenon was not observed for the K1240N mutation, as 287 
replication of this construct was markedly impaired, with luciferase activity barely detected even 288 
at 72 and 96 hours post transfection. Thus while replication of intragenomic constructs carrying 289 
functional NS3-5B in ORF1 and defective NS3-5B in ORF2 might in part depend on a 290 
substitution of the ORF2 replicase by that encoded in ORF1, polyprotein mixing and composite 291 
RC formation appeared to occur also. 292 
To compare how levels of rescue might differ using trans-complementation, a stable 293 
replicon cell line expressing functional NS3-5B was transfected with a bicistronic subgenomic 294 
replicon encoding a firefly luciferase reporter in ORF1 and a functional or mutated (NS3K1240N, 295 
NS4BG1911A, NS5AP2008A, NS5AS2208I and NS5BGDD>GAA) NS3-5B polyprotein in ORF2. 296 
Consistent with reports from other studies, only robust rescue of NS5AS2208I was observed, with 297 
levels of luciferase activity being approximately 10% of those levels seen for the functional 298 
control construct (Fig 3b). Other mutations were either rescued at a low levels (NS4BG1911A and 299 
NS5AP2008A) or not at all (NS3K1240N and NS5BGDD>GAA). As expected, none of the mutated 300 
transcripts replicated when transfected into naive Huh7.5 cells (Fig 3c).  301 
NS3 helicase mutation K1240N is dominant negative 302 
The inability to rescue the NS3 K1240N mutation in ORF2 using constructs where ORF1 303 
expressed wt NS3-5B was potentially consistent with the formation of composite NS protein 304 
complexes where the mutation in the NS3 helicase had a dominant negative effect on replication. 305 
To test this the K1240N mutation was introduced into ORF1 of the intragenomic replicon 306 
carrying a functional NS3-5B in ORF2 and the impact on replication was assessed (Fig 4a). To 307 
maximise the utility of the intragenomic system, the constructs examined included those 308 
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expressing NS34A, NS3-5A and NS3-5B from ORF1, with these polyproteins containing both 309 
wt sequences and the K1240N mutation.  310 
 From monitoring luciferase levels in cells transfected with the various constructs, 311 
K1240NNS34A/wtNS3-5B had comparable levels of replication to its counterpart expressing 312 
functional NS34A from ORF1 (Fig 4a). In contrast, expressing the K1240N mutation from NS3-313 
5A ORF1 (K1240NNS3-5A/wtNS3-5B ) gave a noticeable drop in replication of approximately 10-314 
fold in the first 48 hours compared to wtNS3-5A/wtNS3-5B, although replication recovered to some 315 
extent at later time points. The impact of expressing K1240N from the NS3-5B ORF1 was even 316 
greater, with replication levels of ~20-30 fold lower than the comparable control construct during 317 
the first 48 hours and remaining low over the course of 96 hours.  318 
To establish whether a K1240N mutated polyprotein could suppress replication when 319 
expressed from a separate RNA, JFH1-mono was co-transfected into Huh7.5 cells with either 320 
yeast tRNA, or bicistronic subgenomic replicons encoding a firefly luciferase reporter gene in 321 
ORF1 and K1240N or GDD>GAA mutated NS3-5B in ORF2 (Fig 4b). Monitoring firefly 322 
activities in the cells 4 hours and 24 hours post-transfection showed that both bicistronic 323 
replication defective transcripts were present at broadly similar levels and exhibited a similar rate 324 
of decay. Despite this, the replication of JFH1-mono was significantly inhibited in the presence 325 
of K1240N NS3-5B (replication ~30-55% of that of the tRNA group over 24 to 96 hours). In 326 
contrast, inhibition was not seen in the presence of GDD>GAA mutated NS3-5B, indicating that 327 
reduced replication imposed by K1240N was not due to competition between NS proteins for 328 
limited host cell factors (24).  329 
Intragenomic replicon replication of constructs carrying the T1299A helicase mutation differs 330 
from those carrying the K1240N mutation. 331 
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Kazakov et al. (18) recently proposed NS3 helicase activity to be cis-acting on the basis 332 
that several mutations blocking NS3 helicase activity could not be trans-complemented using 333 
various systems expressing NS3-5B. However, the fact that K1240N imposed a trans-dominant 334 
negative phenotype on replication offered a potential alternative explanation as to why rescue of 335 
helicase mutations had not been observed. It was therefore important to examine whether another 336 
mutation (T1299A), which disrupts helicase binding to the phosphate backbone of nucleic acid 337 
and used in the aforementioned study, might also be dominant negative. Hence, T1299A was 338 
introduced into ORF1 in a series of intragenomic replicons, and the impact it had on ORF2 339 
replicase activity assessed by comparing replication of these constructs with that of their 340 
counterparts expressing functional polyprotein from ORF1. Remarkably, replication was 341 
unaffected by the presence of T1299A, irrespective of whether it was expressed from ORF1 342 
NS3-5A or NS3-5B polyproteins (Fig 4c). In contrast, a control transcript expressing K1240N 343 
from NS3-5B ORF1 did show suppressed replication. 344 
If T1299A was not dominant negative, as our data suggested, this provided an 345 
opportunity to examine the extent to which ORF1 could replace the cis-acting role of ORF2. 346 
Therefore, T1299A was introduced into ORF2 of an intragenomic replicon expressing functional 347 
NS3-5A or NS3-5B from ORF1. Transfection of these transcripts into Huh7.5 cells revealed that 348 
while replication was not supported by ORF1 expressing NS3-5A, replication was detected with 349 
the construct expressing functional NS3-5B from ORF1 (Fig 4d). We conclude that while NS3 350 
helicase activity is likely to be a cis-acting function of the replicase, mutations disrupting this 351 
activity can manifest additional phenotypes, as seen with K1240N exerting a dominant negative 352 
effect on replication. We further conclude that ORF1 NS3-5B can substitute for cis-acting 353 
functions normally provided by the authentic NS3-5B replicase expressed from ORF2. 354 
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Establishing that NS4B, NS5A and NS5B mutations depend on NS3-5B for rescue. 355 
 The data above indicated that NS3-5B expressed from ORF1 of an intragenomic replicon 356 
was capable of replacing the cis-acting functions of ORF2.  To further exploit the potential of the 357 
intragenomic replicon system, mutations were introduced into wtNS3-5B/wtNS3-5B in different 358 
combinations and permutations. Initially, we placed the NS4B G1911A mutation in ORF1 and 359 
the NS5A P2008A mutation in ORF2 to create G1911ANS3-5B/P2008ANS3-5B. RNA from this 360 
construct and other controls was transfected into Huh7.5 cells, and replication was assessed by 361 
measuring luciferase activity (Fig 5a). The pattern of reporter activity for wtNS3-5B/wtNS3-5B, 362 
wtNS3-5B/G1911ANS3-5B and wtNS3-5B/P2008ANS3-5B was identical to that seen in Fig. 3. 363 
Interestingly, G1911ANS3-5B/P2008ANS3-5B also replicated at levels that were only about 3–fold 364 
less than that for either wtNS3-5B/G1911ANS3-5B or wtNS3-5B/P2008ANS3-5B in contrast to 365 
GDD>GAANS3-5B/ΔGDDNS3-5B which did not replicate. Northern blot analysis (Fig 5b) revealed 366 
that RNA identical in length to in vitro transcribed wtNS3-5B/wtNS3-5B transcripts was clearly 367 
present in cells 72 hours after transfection with wtNS3-5B/wtNS3-5B, wtNS3-5B/G1911ANS3-5B and 368 
wtNS3-5B/P2008ANS3-5B. A similar sized band, albeit at a much reduced level was also seen in cells 369 
transfected with G1911ANS3-5B/P2008ANS3-5B. No obvious band of this size was observed in cells 370 
transfected with the polymerase knock-out control intragenomic replicon. As neither G1911A 371 
nor P2008A could be rescued by NS3-5A, we conclude that composite complexes must have 372 
formed from the mixing of two defective NS3-5B polyproteins.  373 
Rescue of replication is proposed to occur through exchange of NS proteins between 374 
individual polyprotein-derived complexes (18). However, published data suggest that rescue of 375 
NS5B defects instead depends on strand exchange, a process where the viral RNA transfers from 376 
an NS5B-containing complex derived from one NS3-5B ORF to another NS5B-containing 377 
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complex derived from a second NS3-5B ORF (18). Under such circumstances, NS3-5B provided 378 
in trans is only able to rescue polymerase defects if it itself carries no lethal mutations. Our 379 
intragenomic replicon system provided an opportunity to examine rescue of defective NS5B 380 
under conditions where two polyproteins were translated from the same RNA. Therefore, 381 
constructs were made in which the NS4B mutation G1911A was combined with the polymerase 382 
knock out mutation GDD>GAA to give GDD>GAANS3-5B/G1911ANS3-5B (Fig 5c). This construct 383 
replicated at lower levels than wtNS3-5B/wtNS3-5B or single mutated control constructs wtNS3-384 
5B/G1911ANS3-5B and wtNS3-5B/GDD>GAANS3-5B, but still generated a luciferase signal 100-fold 385 
higher than the replication defective construct GDD>GAANS3-5B/∆GDDNS3-5B. The two mutations 386 
were subsequently switched between ORF1 and ORF2, resulting in the generation of 387 
G1911ANS3-5B/GDD>GAANS3-5B. Again, low but detectable levels of replication were seen in 388 
cells transfected with this replicon (Fig. 5d). The fact that both GDD>GAANS3-5B/G1911ANS3-5B 389 
and G1911ANS3-5B/GDD>GAANS3-5B replicate further supports the view that ORF1 and ORF2 390 
within the intragenomic replicon are each capable of contributing replicase cis-acting functions. 391 
To confirm rescue of a polymerase defect in cis required NS5B to be expressed in the context of 392 
a polyprotein, intragenomic replicons were made expressing NS5B or NS5A5B in ORF1 and 393 
encoding either a functional or polymerase-defective replicase in ORF2 (Fig 5e). Upon 394 
transfection into Huh7.5 cells, only those constructs encoding a functional NS3-5B in ORF2 395 
replicated, indicating that rescue of polymerase activity is indeed dependent on expression of 396 
functional NS5B in the context of a polyprotein, most probably NS3-5B. 397 
Having established that G1911A and GDD>GAA were dependent on NS3-5B for rescue, 398 
we combined these same mutations in ORF2 with the helicase mutation T1299A in ORF1. 399 
Interestingly, transfection of the resulting transcripts into Huh7.5 cells revealed that neither 400 
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combination of mutations supported intragenomic replicon replication (Fig 5f). Thus despite 401 
evidence that composite replication complexes are formed between NS3-5B expressed from both 402 
ORFs, it appears that neither G1911A nor GDD>GAA mutated NS3-5B can substitute for the 403 
cis-acting role of a T1299A mutated polyprotein. The implications of this are discussed later, but 404 
suggest that each NS3-5B polyprotein which contributes to functional NS3-5B-dependent 405 
complex formation requires helicase activity. 406 
Overall, our results show that complementation of some mutations in the NS3-5A region 407 
are indeed dependent on NS3-5B. The data also further supports the notion that ORF1 can 408 
substitute for ORF2 cis-acting interactions and that helicase activity provided both in cis and in 409 
trans is critical for NS3-5B dependent complex formation. 410 
Lethal mutations in NS3 and NS4A exist that can be rescued in the intragenomic system 411 
  The above data indicated that all NS3 mutations which blocked helicase activity were 412 
refractile to complementation. To determine whether this was representative of all mutations in 413 
NS3, and its co-factor NS4A, we selected four further mutations in these proteins that were lethal 414 
to replication but did not cause defective polyprotein processing (25-28). Two mutations were in 415 
NS3, mapping to the protease domain (L1157A) and hinge region between the protease and 416 
helicase domains (PP1220-1GG) respectively. The other two mutations were situated at either 417 
end of NS4A (V1665G and Y1706A), the former locating to and disrupting NS4A trans-418 
membrane dimerization and the later representing an essential conserved residue within the 419 
acidic domain of NS4A. 420 
The mutations were introduced into ORF2 of intragenomic replicons that expressed 421 
NS34A, NS3-5A or NS3-5B from ORF1. All constructs expressing NS34A were replication 422 
defective (Fig 6a). In contrast, three of the constructs (L1157A, PP1220-1GG and Y1706A) 423 
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replicated when ORF1 instead expressed NS3-5A; luciferase values indicated that L1157A was 424 
rescued most efficiently, followed by PP1220-1GG and then Y1706A. When ORF1 expressed 425 
NS3-5B, replication occurred for all four mutations. For L1157A, PP1220-1GG and Y1706A 426 
levels of replication were broadly comparable, while they were lower but still detectable for 427 
V1665G. To establish whether this latter mutation was rescuable in an NS3-5B dependent 428 
manner, the mutation was introduced into ORF2 of an intragenomic construct expressing an 429 
NS4B G1911A mutated NS3-5B from ORF1. For comparison, constructs expressing wt NS3-5B 430 
from ORF1 and V1665G or G1911A mutated NS3-5B from ORF2 were included. Transfection 431 
into Huh7.5 cells revealed that for those constructs carrying only a single mutation in ORF2, 432 
V1665G had a more inhibitory effect on replication compared to G1911A (Fig 6b). The replicon 433 
carrying G1911A in ORF1 and V1665G in ORF2 did not replicate. The fact that wtNS3-434 
5B/V1665GNS3-5B replicated at a noticeably lower level than wtNS3-5B/G1911ANS3-5B suggested that 435 
V1665G might exert a dominant negative phenotype. To establish whether this was the case, the 436 
mutation was introduced into NS3-5A or NS3-5B expressed from ORF1 (Fig 6c) and the 437 
replication of these intragenomic constructs compared to the equivalent constructs expressing 438 
functional NS3-5A and NS3-5B from ORF1. Interestingly, the presence of V1665G in ORF1 439 
suppressed replication compared to equivalent constructs expressing functional polyprotein, but 440 
only when ORF1 encoded NS3-5B. It therefore appears that V1665G is dominant negative, but 441 
unlike the K1240N NS3 helicase mutation only manifests this phenotype when expressed in the 442 
context of a full length replicase. 443 
To compare levels of rescue with that seen using trans-complementation, all four 444 
mutations were introduced into a bicistronic subgenomic replicon encoding a firefly luciferase 445 
reporter in ORF1. A stable cell line expressing a functional replicon was transfected with these 446 
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constructs along with control constructs carrying the GDD>GAA, G1911A and S2208I 447 
mutations to allow comparisons to be made with earlier experiments (Fig 6d). Other than 448 
GDD>GAA and V1665G, all mutations showed some degree of complementation. For the NS3 449 
mutation L1157A and NS4A mutation Y1706A levels of rescue were only slightly less than 450 
observed for the NS5A mutation S2208I. In contrast, rescue of the other NS3-5A dependent 451 
mutation in NS3, PP1220-1GG, was lower and comparable to that seen for the NS3-5B 452 
dependent mutation G1911A in NS4B. None of the mutated constructs replicated when 453 
transfected into naive Huh7.5 cells (data not shown). It was interesting that Y1706A was rescued 454 
as efficiently as L1157A given the limited extent to which the former mutation was rescued by 455 
NS3-5A when expressed from ORF1 of an intragenomic replicon. We therefore transfected the 456 
same firefly replicon constructs into Huh7.5 cells transduced with baculovirus expressing NS3-457 
5A (Fig 6e). While the data confirmed that rescue of L1157A, PP1220-1GG and Y1706A 458 
required expression of a minimum NS3-5A polyprotein, these levels were reasonably 459 
comparable for L1157A and Y1706A, similar to the situation using helper replicons.  460 
We conclude that like NS5A, there are mutations in NS34A capable of being rescued by 461 
a minimum NS3-5A precursor whereas others are not. Rescue of mutations dependent on a 462 
minimum NS3-5A polyprotein is possible when this protein is expressed in cis from ORF1 or in 463 
trans from a separate mRNA.  464 
Blocking NS4B5A cleavage only impacts on functions within complexes dependent on NS3-5B 465 
expression 466 
Since cleavage between NS4B and NS5A by NS3/4A is slower than at other boundary 467 
sites in the NS3-5B polyprotein, we and others have proposed that the presence of a NS4B5A 468 
precursor within a complex destined to form the RC might serve as a check-point to prevent 469 
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premature membrane deformation events linked to RC maturation (29, 30). Given our data 470 
suggesting that NS3-5A and NS3-5B provide differential access to different NS protein 471 
complexes supporting replication, we were interested to know the impact that blocking cleavage 472 
of NS4B5A would have in the context of the intragenomic replicon system.  473 
In the first instance an NS5A mutation, S1977P, designed to block NS4B5A boundary 474 
cleavage, was introduced into ORF2 of an intragenomic replicon expressing NS3-5B in ORF1. 475 
Transfection of this construct into Huh7.5 cells showed that, compared to a control construct 476 
carrying the NS5A P2008A mutation in ORF2, replication was considerably impaired (Fig 7a). 477 
S1977P was then introduced into NS3-5A or NS3-5B expressed from ORF1 of an intragenomic 478 
replicon (Fig 7b). As was observed for the K1240N and V1665G mutation, NS3-5B expressed 479 
from ORF1 carrying the S1977P mutation measurably impaired replication (Fig. 7b). Similar to 480 
the V1665G mutation but unlike the K1240N mutation, S1977P failed to inhibit replication when 481 
expressed from ORF1 in the context of NS3-5A. Western blot analysis confirmed the presence of 482 
uncleaved NS4B5A from ORF1 in cell extracts from cells transfected with S1977PNS3-5A/wtNS3-5B 483 
and S1977PNS3-5B/wtNS3-5B (Fig. 7c). These data suggested that S1977P had dominant negative 484 
activity, albeit only when expressed in the context of NS3-5B. This was verified by comparing 485 
the impact that K1240N, S1977P, G1911A and GDD>GAA mutations in ORF1 had on 486 
replication (Fig 7d). Critically, only K1240N and S1977P markedly suppressed replication while 487 
the other mutations exhibited little or no effect. 488 
Two possible explanations might account for the failure of NS3-5A carrying the 489 
NS5AS1977P mutation to inhibit replication. The first was that complexes formed by NS3-5A 490 
tolerated the presence of an uncleaved NS4B5A precursor, unlike those formed by NS3-5B. The 491 
second possibility was that the mutation had prevented integration of NS4B5A into NS3-5A-492 
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dependent complexes. As this latter event might have allowed dissociation of NS4B5A from the 493 
MAF, confocal analysis was employed to examine the location of NS4B5A precursor from 494 
S1977PNS3-5A/wtNS3-5B with respect to the functional NS5A expressed from ORF2. Results 495 
showed that extensive overlap of signals was evident (Fig 8a). 496 
To further investigate the impact of S1997P on NS3-5A-dependent complex formation 497 
we took advantage of our earlier observation that rescue of the NS5A S2208I mutation occurred 498 
extremely efficiently using NS3-5A, reasoning that if S1977P NS3-5A still formed NS3-5A 499 
dependent complexes it might be able to rescue this latter mutation. Intragenomic constructs 500 
carrying S1977P mutated NS3-5A and NS3-5B in ORF1 were therefore further modified to carry 501 
the S2208I mutation in ORF2. Remarkably, despite being unable to produce mature NS5A, a 502 
NS3-5A polyprotein carrying S1977P expressed from ORF1 could rescue replication when 503 
ORF2 contained the S2208I mutation (Fig 8b), albeit 3-4 fold less efficiently than when ORF1 504 
expressed functional NS3-5A. By contrast, the construct expressing S1977P mutated NS3-5B 505 
from ORF1 and S2208I mutated NS3-5B in ORF2 barely replicated. To verify this result, trans-506 
complementation of the S2208I mutation was examined under conditions where functional 507 
NS5A, functional NS3-5A and S1977P mutated NS3-5A were provided by baculovirus 508 
transduction (Fig 8c). While wt NS3-5A was most effective at rescuing the S2208I mutation, 509 
expression of S1977P mutated NS3-5A also resulted in a substantial level of rescue that was 510 
several fold higher than seen using NS5A alone. Western blot analysis (Fig 8d) established that 511 
NS5A expression was greatest in NS5A and lowest in NS3-5AS1977P transduced cells, indicating 512 
that expression levels do not account for the improved rescue of S2208I with NS3-5AS1977P 513 
versus NS5A alone. 514 
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To extend our analysis to another defect in NS5A, we selected a further mutation 515 
(G2323A) belonging to a different intragenic complementation group to that of S2208I and 516 
P2008A (17). This mutation was introduced into ORF2 of a series of intragenomic constructs 517 
expressing either wt NS3-5A, S1977P mutated NS3-5A or wt NS3-5B from ORF1. Transfection 518 
of the RNAs into Huh7.5 cells revealed that NS3-5A was able to efficiently rescue G2323A and 519 
that this still occurred, albeit at slightly lower levels when ORF1 instead carried a S1977P 520 
mutated NS3-5A (Fig 8e). On the basis of these combined results we conclude that at least some 521 
NS5A functions operate within an NS3-5A dependent complex that is physically distinct from 522 
that formed by NS3-5B/NS3-5B interactions. 523 
    524 
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Discussion 525 
Our results demonstrate that the truncated polyprotein NS3-5A, although able to target 526 
NS protein components to MAF, can only complement certain replication defects contained in 527 
this same coding region. As replication depends on homo and heterotypic interactions between 528 
different NS proteins within NS3-5B (18, 31-36), functional NS-NS protein complex formation 529 
would explain this observation. Our proposal is that the inability to rescue certain mutations by 530 
NS3-5A is due to this precursor participating in the formation of only a subset of complexes 531 
formed by NS3-5B/NS3-5B interactions. Evidence supporting this conclusion comes from 532 
several observations. Firstly, two mutations in the NS3-5A coding region were not 533 
complemented by NS3-5A but were efficiently rescued by NS3-5B. While this rescue, in theory, 534 
could be due to NS3-5A being less efficient at forming the same complexes as NS3-5B, 535 
experimental data suggests otherwise. We identified one mutation (PP1220-1GG) whose defect 536 
was rescued by NS3-5A, yet the same mutation showed comparable rescue to the NS3-5B-537 
dependent defects G1911A and P2008A using helper virus. Secondly, despite the fact that the 538 
three dominant mutations, K1240N, V1665G and S1977P, inhibited replication to broadly 539 
similar levels when expressed in the context of NS3-5B, only K1240N inhibited replication when 540 
expressed as an NS3-5A precursor. Finally, expression of the dominant negative mutation, 541 
S1977P, in the context of a NS3-5A precursor enabled rescue of two NS5A mutations belonging 542 
to different intragenic groupings. Given that all three mutations are on the same protein, it seems 543 
probable that S1977P expressed from NS3-5A must be selectively incorporated into an NS5A-544 
containing complex disabled by either S2208I or G2323A, while being excluded from another 545 
complex for which S1977P itself is lethal.  546 
Rescue of replication defective mutations in positive strand RNA viruses has typically 547 
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employed trans-complementation systems, where the functional protein or polyprotein is 548 
expressed from an RNA separate to the one being rescued. While our study is not the first to 549 
produce two copies of an NS protein from a replication competent RNA, it is the first to express 550 
an entire duplicated replicase. Use of similar constructs has proven problematic in the past. 551 
Rescue that relied on the placement of duplicated NS coding regions in poliovirus found the 552 
duplicated sequence was rapidly lost (37), presumably because of selective pressures arising 553 
from use of infectious virus with larger than unit sized genomes and subsequent packaging 554 
constraints which this imposed. In addition, the use of virus rather than replicons meant these 555 
selection pressures operated across an entire cell population rather than within individual 556 
transfected cells. By using replicons carrying the second copy of the NS polyprotein as a re-557 
coded sequence, we have studied replication under transient conditions where recombination, if 558 
it occurs, makes little or no contribution to the overall assay readout. Supporting this view, we 559 
found that constructs expressing functional NS3-5A from ORF1 and NS3-5B from ORF2 failed 560 
to generate a replication signal when ORF2 carried mutations K1240N, V1665G, G1911A and 561 
P2008A, despite the fact that a single recombination event had the potential to generate 562 
replication competent monomeric transcripts. Northern blot analysis of replication assays 72 563 
hours post transfection also showed that the replicon transcripts present in cells were the same 564 
size as the input transcripts. Tight temporal and spatial control of expression obtained from 565 
producing the two replicases from the same RNA makes the intragenomic replicon systems a 566 
potentially valuable tool for studying replication of other positive strand RNA viruses. That NS3-567 
5B expressed from either ORF is able to assume cis-acting roles in replication adds further value 568 
to the system as it provides opportunities to look at replication complex formation in ways that 569 
have not been possible until now.  570 
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RNA replication depends not only on viral polyprotein expression, but also on the 571 
interactions between these polyprotein components and RNA elements present in the genome. In 572 
HCV, the NS3-5B coding region lies adjacent to the 3’UTR and contains cis-acting RNA 573 
elements within its 3’ end that make essential kissing loop interactions (22, 23, 38). Remarkably, 574 
there is no requirement for the NS3-5B coding region to overlap the kissing loop structure (38), 575 
although until now it has been unclear whether there is a spatial relationship between the NS3-576 
5B ORF and the 3’ end of the genome. By demonstrating that NS3-5B expressed from ORF1 of 577 
an intragenomic replicon can support replication when ORF2 caries the cis-acting NS3 helicase 578 
mutation T1299A (18), our data indicates that a considerable distance between the polyprotein 579 
ORF and 3’UTR can be tolerated. This conclusion is further supported by our finding that 580 
intragenomic constructs expressing two NS3-5B polyproteins, each with separate mutations in 581 
NS4B (G1911A) or NS5B (GDD>GAA), still replicate, irrespective of which ORF the two 582 
mutations are placed in. Based on studies by others (18), such combinations would not be 583 
tolerated if ORF1 did not assume cis-acting functions normally provided by the authentic 584 
replicase encoded in ORF2.  585 
As our data showed ORF1 is able to substitute for the cis-acting role of ORF2, it was 586 
surprising to see that intragenomic constructs carrying the cis-acting NS3 helicase mutation 587 
T1299A in ORF1 were unable to tolerate the presence of the NS4B G1911A mutation in ORF2. 588 
This was despite the fact that neither of these mutations were dominant negative and data from 589 
both this study and others show that the function blocked by G1911A is not cis-acting (14). 590 
Given NS3-5A expressed from ORF1 of an intragenomic replicon cannot rescue T1299A in 591 
ORF2, and G1911A requires NS3-5B for rescue, it seems likely that both cis-acting and trans-592 
acting events blocked by these two mutations localize to an NS3-5B containing complex which 593 
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NS3-5A is excluded from. Based on this conclusion and other observations, we propose the 594 
following model where formation of this complex involves an association of multiple copies of 595 
an NS3-5B precursor shortly after their translation. Firstly, polyprotein association is catalysed 596 
by an initial binding event between a cis-acting replication element (CRE) within the RNA 597 
genome and NS3 helicase, as has been suggested by others (18). However, subsequent assembly 598 
requires the presence of NS5B as a structural component, both in the polyprotein that makes the 599 
cis-acting contact with the viral RNA, as well as in the polyproteins that engage in trans with this 600 
initial cis-acting complex. This requirement for NS5B has similarities to the model put forward 601 
by Kazakov et al (18), who suggested the protein provided a structural component for cis-602 
dependent interactions, but did not identify similar role for it in trans. A further distinguishing 603 
feature of our model is that incorporation of NS3-5B into this growing complex also requires the 604 
newly arriving polyproteins to display NS3 helicase RNA binding activity. In other words, NS3 605 
helicase has both essential cis- and trans-acting roles in NS3-5B-dependent complex formation. 606 
Figure 9 illustrates this as well as how assembly of such a complex would be influenced by 607 
different mutations used in this study. Importantly, some of the predictions made by our model 608 
can account for the findings of others. It has been shown that replication of viral transcripts 609 
expressing NS3-5A in cis cannot be supported by expression of NS3-5B in trans (18), despite the 610 
fact that replication of mini-genomes which fail to express viral proteins can be supported by 611 
expression of a viral replicase (39). Our model offers the possibility that NS3-5A expressed in 612 
cis is capable of making non-productive interactions with CRE elements in the viral genome, 613 
thus frustrating assembly of the NS3-5B-dependent complex. Perhaps relating to this mode of 614 
action, we identified one mutation, NS4AY1706A, which was rescued far more effectively when 615 
NS3-5A was expressed in trans from a separate RNA than in cis when expressed from ORF1 of 616 
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an intragenomic replicon. Identifying mutations in ORF2 NS3-5B that weaken its ability to 617 
outcompete ORF1 expressed NS3-5A for  binding to CRE elements could provide useful 618 
information about protein-protein and protein-RNA contacts made during complex assembly. 619 
While the NS4AY1706 residue is relatively conserved, it does lie adjacent to another more variable 620 
residue (position 1708 in JFH1) previously implicated in orchestrating physical interactions 621 
between NS4A and all other NS proteins within the NS3-5B polyprotein (32). It would be 622 
interesting to see whether mutations of residues such as those identified by co-variant amino acid 623 
analysis alter the ability of different polyproteins expressed in cis to compete for CRE elements.  624 
A general feature of the mutations dependent on NS3-5A for rescue compared to those 625 
dependent on NS3-5B was the greater extent with which they were trans-complemented by a 626 
helper replicon. Reduced levels of stringency for rescue fit with a proposal by Fridell and 627 
colleagues that NS5A supports functions both inside and outside the replication complex (16). 628 
Importantly, they speculated that mutations blocking NS5A function outside and inside the 629 
replication complex included S2208I and P2008A; these mutations which disrupted NS3-5A and 630 
NS3-5B-dependent complex activity respectively in our hands. Compartmentalization of NS3-631 
5A and NS3-5B-dependent complex functions is certainly a possibility that warrants 632 
consideration. Assuming that exchange of individual NS proteins within complexes occurs (18), 633 
without compartmentalization it is difficult to envisage why some mutations in the NS3-5A 634 
region show dependence on NS3-5B for rescue whereas others in the same NS protein are 635 
efficiently rescued by NS3-5A. Furthermore, the proposed role that cleavage of the NS4B5A 636 
boundary has in enabling NS5A driven double membrane formation (29, 30), coupled to the fact 637 
that the S1977P mutation which blocks boundary cleavage is only dominant negative as an NS3-638 
5B precursor, is consistent with NS3-5A-dependent complexes being excluded from the RC. Our 639 
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attempts to see whether discrete compartmentalization occurs have so far been restricted to 640 
confocal microscopy analysis. Given the size of the double membrane vesicles in MAF, the 641 
structures thought to contain the functional replication complexes, it is perhaps not surprising 642 
that we failed to observe separation of NS3-5A versus NS3-5B dependent complexes (data not 643 
shown).  Further physical and electron microscopy studies are planned.  644 
An unexpected outcome of our study was the trans-dominant negative phenotype 645 
displayed by one NS3 helicase mutation (K1240N) but not by another (T1299A). While both 646 
mutations block helicase activity, this occurs through disruption of different sites within the 647 
enzyme. NS3K1240N disrupts the Walker A motif responsible required for ATP binding and 648 
hydrolysis whereas NS3T1299A blocks RNA helicase binding by disrupting the TxGx motif 649 
involved in phosphate backbone interactions (40). Disruption of the Walker A motif would also 650 
have the likely consequence of locking the enzyme in an ATP-free open state, potentially 651 
increasing its propensity to bind RNA compared to wild type NS3 (41). Thus one possible reason 652 
for NS3K1240N displaying a dominant negative phenotype is that it displays either a normal or 653 
enhanced ability to bind to both CRE elements and other RNA sites on the RNA genome, 654 
ensuring that defective NS3 populates NS3-5B dependent complexes. However, the fact that 655 
NS3K1240N was also dominant negative expressed as an NS3-5A precursor suggests that the 656 
inhibitory effect extends beyond the NS3-5B dependent complex. Perhaps the mutated NS3 657 
helicase ‘padlocks’ itself onto viral RNA present within the membranous web, either 658 
immobilizing it and/or preventing functional helicase molecules translocating along it. 659 
Understanding what mechanisms may be involved is important. Studies have already highlighted 660 
the potential importance of trans-dominant mutations in guiding the development of novel viral 661 
inhibitors (42). Should pharmacological recapitulation of this dominant negative phenotype 662 
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prove possible it would provide added therapeutic benefit to any drug targeting helicase activity.  663 
In summary, our work reveals the existence of two functional sets of complexes that 664 
reside within the HCV MAF, both of which are necessary for replication of the viral genome and 665 
each of which performs distinct functions. It seems unlikely that this is a unique mechanism 666 
adopted by HCV. Rescue of defects in pestivirus NS5A show remarkable similarities to that seen 667 
for HCV NS5A, with some but not all mutations being readily rescued by helper virus constructs 668 
(43). Similarly, certain defects in flavivirus NS proteins can be complemented but other defects 669 
in the same protein cannot (44). The intragenomic replicon system represents a potential 670 
powerful approach to investigate the formation and function of complexes, in part due to its 671 
ability to overcome the traditional cis-acting barriers encountered by trans-complementation. 672 
Understanding the roles different complexes play will inform general aspects of viral RNA 673 
replication. 674 
 675 
 676 
  677 
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Figure 1. Schematic representation of the intragenomic HCV replicons used in this study. 819 
The HCV IRES in the 5’UTR drives translation of ORF1 which encodes for indicated NS 820 
polyproteins expressed as part of a Renilla-Foot and Mouth Disease (FMDV) 2A fusion protein. 821 
An encephalomyocarditis virus (EMCV) IRES drives translation of the NS3-5B replicase in 822 
ORF2. When present, NS5A is expressed from ORF1 as a COOH-terminal V5 epitope tagged 823 
protein. Constructs express NS5A from ORF2 as a FLAG tagged protein. Coding regions in 824 
ORF1 downstream from Renilla 2A represent recoded NS sequence incorporating synonymous 825 
sequence alterations compared to authentic viral counterpart sequence present in ORF2. The 826 
table compares the amino acid and nucleotide sequences, as well as the CpG and UpA 827 
frequencies in ORF1 (synthetic sequence) and ORF2 (authentic viral sequences). 828 
 829 
Figure 2. Replication of constructs expressing NS3-5B as a Renilla-FMDV 2A fusion 830 
protein.  Replication was assessed using both monocistronic (a) and intragenomic replicon 831 
constructs (b). The schematic above each graph indicates the regions of NS3-5B encoded by the 832 
recoded and authentic JFH1 coding sequences for each construct. Data represents the mean ± s.d. 833 
from two independent experiments (a) and mean ± s.e.m. from three independent experiments 834 
(b). 835 
 836 
Figure 3. Assessing the capacity of ORF1 polyproteins to support replication of 837 
intragenomic replicons with different defects in ORF2 and recue of the same defects by 838 
trans-complementation. Replication assay data (a) of intragenomic replicons expressing 839 
functional NS3-5A or NS3-5B in ORF1 and expressing NS3-5B carrying a lethal mutation in 840 
ORF2 as defined in the schematic above the graph. These same mutations were introduced into 841 
41 
 
bicistronic replicons expressing firefly luciferase in ORF1 and the capacity of these constructs to 842 
replicated assessed in a stable neoR helper replicon cell line (b) or in naive Huh7.5 cells (c). Data 843 
represents the mean ± s.d. from two independent experiments. 844 
Figure 4. Impact of single helicase point mutations K1240N and T1299A on replicon 845 
replication. Schematics above the graphs provide details of the constructs used and positioning 846 
of mutations within them. Replication assays either employed a single intragenomic replicon 847 
construct per experimental group transfected into Huh7.5 cells (a, c, d) or involved co-848 
transfection of two separate RNAs into naive Huh7.5 cells to assess whether K1240N was 849 
dominant negative in trans (b). Results shown from this latter assay also include the firefly signal 850 
at 4 and 24 hours derived from the replication-defective constructs used. Data represent the mean 851 
± s.d. (a, c, d) or mean ± s.e.m. (b) from 2 and 3 independent experiments respectively. Where 852 
n=3, values significantly different from the control group (mono + tRNA) are highlighted with 853 
an asterisk (p<0.05; 2-tailed t-test). Note: the assay performed to obtain data in (d) was run in 854 
parallel with another described in fig 8e and so share control groups. 855 
Figure 5. Analysis of mutations using the intragenomic replicon and assessing their 856 
dependency on NS3-5B for rescue. Selection of mutations was on the basis that they were 857 
refractile to rescue with ORF1 NS3-5A when present in ORF2, but tolerate when ORF1 instead 858 
expressed NS3-5B. These mutations were introduced into intragenomic replicons in various 859 
combinations and replication assays performed. Schematics above each graph (a, c, d, e, f) 860 
provide details of the constructs used and positioning of mutations within them. Also shown are 861 
Northern blot data (b) using total cellular RNA taken from a replication assay (a). Data represent 862 
the mean ± s.d. from two separate experiments.  863 
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Figure 6. Rescue of lethal mutations in NS3 and NS4A that disrupt processes other than 864 
NS3 helicase activity. Genetic complementation of genetic defects was assessed a variety ways 865 
including use of intragenomic replicons transfected into Huh7.5 cells (a, c), or using bicistronic 866 
replicon expressing firefly luciferase from ORF1 transfected into either a helper replicon cell line 867 
(d) or into naive Huh7.5 cells transduced with either baculovirus expressing NS3-5A or β-868 
galactosidase (mock control) (e). Intragenomic replicons were also used to assess whether 869 
V1665G, which appeared refractile to rescue with NS3-5B, was dominant negative (c). 870 
Schematics above each graph provide specific details of the constructs used and positioning of 871 
mutations within them. Data represent the mean ± s.d. from two separate experiments. 872 
 873 
Figure 7. The effect of blocking NS4B5A boundary cleavage on intragenomic replication. 874 
Schematics provide details of the constructs used and positioning of mutations within them. 875 
Cleavage of the NS4B5A boundary was blocked by the S1977P mutation. The impact this had on 876 
intragenomic replicons, both when it was introduced into ORF2 (a) and ORF1 (b) is shown, with 877 
cell lysates taken from the latter experiment 72 hours post-transfection also analysed by Western 878 
blot (c). Arrows indicate the position of NS5A and the uncleaved NS4B5A precursor. An 879 
asterisk indicates the position of a cross-reacting cellular protein detected by the anti-FLAG 880 
antibody. A replication assay comparing the ability of different mutated NS3-5B ORF1s, 881 
including that of S1977P, to suppress replication of intragenomic replicons carrying functional 882 
ORF2 (d) is also provided. Data represent the mean ± s.d. from two separate experiments. Note: 883 
the assay performed to obtain data in (b) was run in parallel with that described in fig 8b and so 884 
share control groups. 885 
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 886 
 887 
Figure 8. Impact of blocking NS4B5A cleavage on NS3-5A function. In (a) intragenomic 888 
replicons with a functional NS3-5B encoded in ORF2 and expressing either NS5A, NS3-5A or a 889 
S1977P mutated NS3-5A from ORF1 were transfected into Huh7.5 cells. Confocal microscopy 890 
visualized the extent of ORF1 V5-tagged NS5A and ORF2 FLAG-tagged NS5A co-localization 891 
72 hours post transfection. In (b) and (e) intragenomic replicon replication assays detail the 892 
ability of an S1977P mutated polyprotein expressed from ORF1 to complement either the NS5A 893 
S2208I (b) or NS5A G2323A (e) defect in ORF2, the schematics above the graphs indicating 894 
further details of the constructs used. In (c) trans-complementation of a firefly-expressing 895 
bicistronic replicon carrying the S2208I mutation is assessed using Huh7.5 cells transduced with 896 
baculovirus expressing either β-galactosidase (lacZ) or GFP-tagged versions of NS5A, NS3-5A 897 
and NS3-5A carrying the S1977P mutation. Western blot analysis of cell lysates taken 72 hours 898 
post transfection show levels of baculovirus-transduced expression (d). Graphical data represent 899 
the mean ± s.d. from two separate experiments. 900 
 901 
Figure 9. Putative model of NS3-5B dependent complex assembly. In (a) the NS3 helicase 902 
domain within a recently translated polyprotein precursors binds in a cis-dependent manner to 903 
the viral genome (for illustrative purposes the interaction is shown to occur within the 3’UTR X-904 
region). Subsequent recruitment of additional copies of NS3-5B precursor is not a cis-acting 905 
event but does dependent on them possessing both NS5B and helicase-dependent RNA binding 906 
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activity. Our data showing blocking NS4B5A cleavage creates a dominant negative polyprotein 907 
precursor suggests that while complex activity requires completion of polyprotein proteolytic 908 
processing, complex assembly does not. In (b – f) the outcome of NS3-5B dependent complex 909 
formation is shown using the same criteria described above. Replication requires that: (1) 910 
complex assembly occurs; (2) any mutated NS protein present is rescued by a functional 911 
counterpart; (3) a polyprotein carrying a dominant negative mutation is not recruited. 912 
 913 
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3' end of viral ORF 3'UTR
wt (cis)
K1240N (cis)
G1911A (cis)
T1229A (cis)
Binding of RNA by NS3 helicase enhanced by K1240N. K1240N-mutated
NS3-5B over represented in complex and ‘padlocks’ genome, blocking
replication.
Binding of RNA by NS3 helicase blocked by T1299A. T1299A-mutated
NS3-5B unable to make both cis-acting and trans-acting helicase
interactions with RNA. Complex formed exclusively by G12911A-mutated
NS3-5B, blocking replication.
wt (cis)
T1229A (cis or trans)
Binding of RNA by NS3 helicase blocked by T1299A. T1299A-mutated
NS3-5B unable to make both cis-acting and trans-acting helicase
interactions with RNA. Complex formed exclusively by wt
NS3-5B, allowing replication.
wt (trans)
T1229A (cis)
Binding of RNA by NS3 helicase blocked by T1299A. T1299A-mutated
NS3-5B unable to make initial cis-acting interactions with RNA.
Complex fails to form, blocking replication.
G1911A (cis)
GDD>GAA (cis)
Both mutated NS3-5B polyproteins able to undertake cis- and trans-
interactions with viral genome. Composite NS3-5B complex formed
enabling replication.
or
NS3-5B precursor
helicase cis-acting interaction site
helicase trans-acting interaction site
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